17+ years of global biopharma experience across clinical development (Phases I-IV), pharmacovigilance/drug safety, medical affairs, and regulatory strategy. Trusted advisor to biotech CEOs, CROs, and investors, providing fractional and consulting leadership from first-in-human through post-marketing.
Senior physician leadership without permanent executive overhead
Kingsley is a Senior Pharmaceutical Physician with 17+ years of global biopharma experience across clinical development (Phases I-IV), pharmacovigilance/drug safety, medical affairs, and regulatory strategy.
He is UK PMST-certified in Pharmaceutical Medicine and a Fellow of the Faculty of Pharmaceutical Medicine, UK Royal College of Physicians (FFPM-RCP).
Kingsley is a trusted advisor to biotech CEOs, CROs, and investors, providing fractional and consulting leadership from first-in-human through post-marketing.
He has proven ability to de-risk assets, guide regulator-ready programs, and support clinical & safety due diligence for licensing deals, M&A, and asset transactions.
Kingsley brings deep therapeutic breadth spanning cardiorenal-metabolic, oncology, inflammation/immunology, neuroscience, rare diseases, and vaccines.
As founder of NADDBio, he delivers senior physician leadership without permanent executive overhead - enabling biotech and pharma sponsors to access world-class expertise on demand.
Deep experience across multiple therapeutic domains and modalities
Trusted by leading pharmaceutical and biotechnology organizations worldwide
Comprehensive pharmaceutical medicine expertise spanning the full drug development lifecycle
Fellow, Faculty of Pharmaceutical Medicine, UK Royal College of Physicians
Specialist Registration in Pharmaceutical Medicine
Phases I-IV strategy, protocol design, medical oversight
Drug safety, risk management, safety governance
Scientific communications, evidence generation
FDA, EMA, MHRA, PMDA, TGA engagement
Leverage senior pharmaceutical physician expertise for your clinical development, safety, and regulatory needs.